Why 2017 Was a Year to Remember for Illumina, Inc.
Happy days are here again for Illumina, Inc. (NASDAQ: ILMN).
Shareholders were accustomed to huge gains for the stock in previous years, but they were sorely disappointed by the gene-sequencing leader in 2015 and 2016. But 2017 is turning out to be fantastic for Illumina, with its stock rising more than 70% so far this year.
There were hardly any disappointments over the last year -- and plenty of positives. Here's why 2017 was a year to remember for Illumina.
Source: Fool.com
Illumina Inc. Aktie
106,24 €
-6,30 %
Die Community bevorzugt Illumina Inc., mit deutlich mehr Buy- (27) als Sell-Einschätzungen (4).
Ein Kursziel von 162 € für Illumina Inc. würde eine Steigerung von mehr als 50% gegenüber dem aktuellen Kurs von 106.24 € bedeuten.
